Cordyceps Sunshine Biotech Holdings (RAJAF) Buildings (2020 - 2022)

Cordyceps Sunshine Biotech Holdings' Buildings history runs 3 years deep, the most recent figure standing at $635040.0 for Q4 2022.

• In Q4 2022, Buildings fell 7.61% year-over-year to $635040.0; the TTM figure through Dec 2022 stood at $635040.0 (down 7.61% YoY), while the FY2022 annual figure was $635040.0, down 7.61% from the prior year.
• Buildings was $635040.0 for Q4 2022 at Cordyceps Sunshine Biotech Holdings, down from $687318.0 in the prior quarter.
• In the past five years, Buildings ranged from a high of $687318.0 in Q4 2021 to a low of $635040.0 in Q4 2022.
• Historically, Buildings has averaged $664417.3 across 3 years, with a median of $670894.0 in 2020.
• The sharpest annual moves came in 2021 and 2022: Buildings increased 2.45% in 2021, then retreated 7.61% in 2022.
• A 3-year view of Buildings shows it stood at $670894.0 in 2020, then climbed by 2.45% to $687318.0 in 2021, then retreated by 7.61% to $635040.0 in 2022.
• The last three Buildings figures came in at $635040.0 (Q4 2022), $687318.0 (Q4 2021), and $670894.0 (Q4 2020), per Business Quant data.